PL2379086T3 - Preparat farmeceutyczny - Google Patents

Preparat farmeceutyczny

Info

Publication number: PL2379086T3
Authority: PL; Poland
Prior art keywords: pharmaceutical preparation; pharmaceutical; preparation
Prior art date: 2008-12-18

Application number

PL09795982T

Other languages

English (en)

Inventor

Hendrik Jan Ankersmit

Original Assignee

Aposcience Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2008-12-18

Filing date

2009-12-18

Publication date

2016-01-29

2009-12-18 Application filed by Aposcience Ag filed Critical Aposcience Ag

2016-01-29 Publication of PL2379086T3 publication Critical patent/PL2379086T3/pl

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A61K40/10—Cellular immunotherapy characterised by the cell type used
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A61K40/20—Cellular immunotherapy characterised by the effect or the function of the cells
- A61K40/22—Immunosuppressive or immunotolerising
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
- A61K40/41—Vertebrate antigens
- A61K40/416—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
- A61K40/41—Vertebrate antigens
- A61K40/418—Antigens related to induction of tolerance to non-self
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K40/00
- A61K2239/31—Indexing codes associated with cellular immunotherapy of group A61K40/00 characterized by the route of administration
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K40/00
- A61K2239/38—Indexing codes associated with cellular immunotherapy of group A61K40/00 characterised by the dose, timing or administration schedule
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/02—Atmosphere, e.g. low oxygen conditions

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Epidemiology (AREA)
Biomedical Technology (AREA)
Immunology (AREA)
Biotechnology (AREA)
Zoology (AREA)
Wood Science & Technology (AREA)
Genetics & Genomics (AREA)
Physical Education & Sports Medicine (AREA)
Cell Biology (AREA)
Hematology (AREA)
General Engineering & Computer Science (AREA)
Biochemistry (AREA)
Microbiology (AREA)
Rheumatology (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Pain & Pain Management (AREA)
Dermatology (AREA)
Pulmonology (AREA)
Orthopedic Medicine & Surgery (AREA)
Vascular Medicine (AREA)
Transplantation (AREA)
Urology & Nephrology (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

PL09795982T 2008-12-18 2009-12-18 Preparat farmeceutyczny PL2379086T3 (pl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
EP08450199A EP2201954A1 (en)	2008-12-18	2008-12-18	Pharmaceutical preparation
PCT/EP2009/067536 WO2010070105A1 (en)	2008-12-18	2009-12-18	Pharmaceutical preparation
EP09795982.9A EP2379086B1 (en)	2008-12-18	2009-12-18	Pharmaceutical preparation

Publications (1)

Publication Number	Publication Date
PL2379086T3 true PL2379086T3 (pl)	2016-01-29

Family

ID=41381669

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL09795982T PL2379086T3 (pl)	2008-12-18	2009-12-18	Preparat farmeceutyczny

Country Status (14)

Country	Link
US (2)	US10478456B2 (pl)
EP (2)	EP2201954A1 (pl)
JP (1)	JP5869344B2 (pl)
CN (1)	CN102316879B (pl)
AU (1)	AU2009329544B2 (pl)
CA (1)	CA2747207C (pl)
DK (1)	DK2379086T3 (pl)
ES (1)	ES2554624T3 (pl)
HU (1)	HUE028152T2 (pl)
NZ (1)	NZ593365A (pl)
PL (1)	PL2379086T3 (pl)
RU (1)	RU2542512C2 (pl)
WO (1)	WO2010070105A1 (pl)
ZA (1)	ZA201104348B (pl)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP2198873A1 (en) *	2008-12-18	2010-06-23	Aposcience AG	Pharmaceutical preparation comprising supernatant of blood mononuclear cell culture
CN102438635B (zh) *	2009-03-05	2014-09-17	马克罗柯尔有限公司	活化的白细胞组合物
JP6483023B2 (ja) *	2012-12-06	2019-03-13	エンリヴェックスセラピューティクスリミテッド	治療用アポトーシス細胞調製物、その製造方法及びその使用
SMT201800201T1 (it)	2013-01-07	2018-05-02	Inst Nat Sante Rech Med	Trattamento per malattia che utilizza una preparazione farmaceutica tollerogenica
WO2015120077A1 (en) *	2014-02-04	2015-08-13	Gonzalez Jose Javier Lopez	Biologically optimized adult mesenchymal stem cells
US11000548B2 (en)	2015-02-18	2021-05-11	Enlivex Therapeutics Ltd	Combination immune therapy and cytokine control therapy for cancer treatment
US11304976B2 (en)	2015-02-18	2022-04-19	Enlivex Therapeutics Ltd	Combination immune therapy and cytokine control therapy for cancer treatment
CN113106053A (zh)	2015-04-21	2021-07-13	恩立夫克治疗有限责任公司	治疗性汇集的血液凋亡细胞制剂与其用途
EP3416661A4 (en)	2016-02-18	2020-03-04	Enlivex Therapeutics Ltd.	COMBINATION OF IMMUNOTHERAPY AND CYTOKINE CONTROL THERAPY FOR THE TREATMENT OF CANCER
EP3502692A1 (en) *	2017-12-20	2019-06-26	Aposcience AG	Potency assay for secretomes
EP3842064A1 (en)	2019-12-23	2021-06-30	Aposcience AG	Composition for treating or preventing an allergy or allergic reaction
EP4074320A1 (en)	2021-04-13	2022-10-19	Aposcience AG	Treatment of skin scars
EP4197547A1 (en)	2021-12-20	2023-06-21	Aposcience AG	Composition for treating or preventing vasculitis and diseases associated with vasculitis
WO2024105193A1 (en) *	2022-11-17	2024-05-23	Koptyug Andrey V	Novel compounds and methods
WO2024227265A1 (en)	2023-05-03	2024-11-07	Volumina Medical Sa	Devices and methods for preparing and conditioning biological assemblies for minimally invasive delivery for tissue engineering, cell therapies and other therapeutic applications
EP4628570A1 (en)	2024-04-03	2025-10-08	Aposcience AG	Method for cultivating mammalian cells

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0080600B1 (fr) *	1981-11-27	1985-06-19	Firmenich Sa	Utilisation de 2-hydroxy-3,4,4-triméthyl-cyclopent-2-ène-1-one à titre d'ingrédient odoriférant
AU2003230321B8 (en) *	2002-05-09	2009-07-30	Medigenes	A pharmaceutical composition for treatment of wounds containing blood plasma or serum
US20070110737A1 (en) *	2003-12-29	2007-05-17	Allan Mishra	Compositions and method for decreasing the appearance of skin wrinkles
RU2262941C2 (ru) *	2004-01-05	2005-10-27	Государственное учреждение Научно-исследовательский институт клинической иммунологии СО РАМН	Способ иммунотерапии злокачественных опухолей головного мозга
AU2005219660B2 (en) *	2004-03-09	2009-07-16	Absorber Ab	Endothelial progenitor cells and methods of use thereof
WO2005123107A2 (en) *	2004-06-09	2005-12-29	Research Development Foundation	Immune response suppressor and treatment of multiple sclerosis
US20060004189A1 (en) *	2004-07-02	2006-01-05	James Gandy	Compositions for treating wounds and processes for their preparation
CN100552022C (zh) *	2004-09-20	2009-10-21	上海市第一人民医院	一种诱导分化人外周血单个核细胞的方法
UA94046C2 (ru) *	2005-06-24	2011-04-11	Кадила Хелткере Лимитед	Пептиды, производные от тромбоспондина-1, и способы лечения
CN101484008A (zh) *	2006-05-03	2009-07-15	特拉科斯有限公司	用于治疗涉及应激相关疾病和病症的疾病的方法

2008
- 2008-12-18 EP EP08450199A patent/EP2201954A1/en not_active Withdrawn
2009
- 2009-12-18 DK DK09795982.9T patent/DK2379086T3/en active
- 2009-12-18 HU HUE09795982A patent/HUE028152T2/en unknown
- 2009-12-18 US US13/140,120 patent/US10478456B2/en active Active
- 2009-12-18 NZ NZ593365A patent/NZ593365A/xx unknown
- 2009-12-18 AU AU2009329544A patent/AU2009329544B2/en active Active
- 2009-12-18 ES ES09795982.9T patent/ES2554624T3/es active Active
- 2009-12-18 CA CA2747207A patent/CA2747207C/en active Active
- 2009-12-18 EP EP09795982.9A patent/EP2379086B1/en active Active
- 2009-12-18 CN CN200980156610.8A patent/CN102316879B/zh active Active
- 2009-12-18 PL PL09795982T patent/PL2379086T3/pl unknown
- 2009-12-18 JP JP2011541478A patent/JP5869344B2/ja active Active
- 2009-12-18 WO PCT/EP2009/067536 patent/WO2010070105A1/en not_active Ceased
- 2009-12-18 RU RU2011129672/15A patent/RU2542512C2/ru active
2011
- 2011-06-10 ZA ZA2011/04348A patent/ZA201104348B/en unknown
2019
- 2019-11-18 US US16/687,115 patent/US20200254019A1/en not_active Abandoned

Also Published As

Publication number	Publication date
EP2201954A1 (en)	2010-06-30
HUE028152T2 (en)	2016-11-28
RU2542512C2 (ru)	2015-02-20
CN102316879B (zh)	2014-01-22
RU2011129672A (ru)	2013-01-27
ES2554624T3 (es)	2015-12-22
AU2009329544B2 (en)	2015-01-22
US10478456B2 (en)	2019-11-19
WO2010070105A1 (en)	2010-06-24
JP5869344B2 (ja)	2016-02-24
DK2379086T3 (en)	2015-10-05
US20200254019A1 (en)	2020-08-13
CA2747207A1 (en)	2010-06-24
BRPI0922173A2 (pt)	2015-12-29
AU2009329544A1 (en)	2011-07-07
EP2379086B1 (en)	2015-09-02
CA2747207C (en)	2017-11-21
JP2012512843A (ja)	2012-06-07
US20110250190A1 (en)	2011-10-13
ZA201104348B (en)	2012-02-29
EP2379086A1 (en)	2011-10-26
CN102316879A (zh)	2012-01-11
NZ593365A (en)	2012-11-30

Publication	Publication Date	Title
CY2018030I2 (el)	2019-11-27	Φαρμακοτεχνικη μορφη 514
PL2379086T3 (pl)	2016-01-29	Preparat farmeceutyczny
BRPI0920521A2 (pt)	2018-01-16	combinação farmacêutica
DK3097925T3 (da)	2019-08-05	Farmaceutisk sammensætning
EP2240022A4 (en)	2012-04-25	PHARMACEUTICAL COMPOSITIONS
BRPI1004940A2 (pt)	2018-06-19	composição farmacêutica
BRPI0912213A2 (pt)	2015-10-06	preparação cosmética
BRPI0807453A2 (pt)	2014-05-20	Preparação sólida
SMT201400069B (it)	2014-07-07	Formulazione farmaceutica
EP2351549A4 (en)	2015-06-24	INTERCONNECTS
SMT201700095B (is)	2017-03-08	Composizioni farmaceutiche per inalazione
BRPI0721651A2 (pt)	2014-04-01	Composição farmacêutica
BRPI0912026A2 (pt)	2015-10-06	formulação homeopática
EP2373681A4 (en)	2013-11-06	PHARMACEUTICAL COMPOSITIONS
EP2451274A4 (en)	2014-04-02	Pharmaceutical compositions
EP2419097A4 (en)	2012-09-05	PHARMACEUTICAL COMPOSITIONS
DK2285357T3 (da)	2014-06-02	Farmaceutisk sammensætning omfattende brivaracetam
BRPI1015939A2 (pt)	2016-09-27	composição farmacêutica
BRPI0921654A2 (pt)	2016-02-10	formulação farmacêutica
DK2285413T3 (da)	2012-08-27	Farmaceutisk sammensætning
DK2125048T3 (da)	2014-10-13	Præparat
DK2391349T3 (da)	2014-11-03	Farmaceutisk sammensætning omfattende 2-oco-1-pyrrolidin-derivater
EP2236149A4 (en)	2012-12-26	MEDICAL COMPOSITION
DK2120884T3 (da)	2011-02-07	Farmaceutisk sammensætning
BRPI0921313A2 (pt)	2015-12-29	composição farmaucêutica